If this press release is not displaying properly, read this release online.

Imedex

March 9, 2017

Important Advancements in Gastrointestinal Cancers to be Presented at 2017 Great Debates and Updates in Gastrointestinal Malignancies Conference

(New York, NY) — Great Debates and Updates in Gastrointestinal Malignancies, an annual conference taking place in New York, NY March 24-25, 2017 and organized by Imedex, LLC, will gather the leading researchers and healthcare professionals in the field of gastrointestinal oncology for an interactive, 2-day, debate-driven discussion. The conference will highlight key advances surrounding the diagnosis and management of a broad continuum of gastrointestinal malignancies, including esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. Faculty and audience discussion will focus on how new information can be applied to current community practice.

"I don't think there is any meeting out there which delivers so much information on how to treat patients with GI malignancies in such a comprehensive and entertaining way." - Axel Grothey, MD, Co-Chair

Given the plethora of clinical trials, emerging data and ongoing clinical controversies, community oncologists will greatly benefit from expert guidance on important issues in optimizing the management of patients with GI malignancies. In addition, Great Debates and Updates in Gastrointestinal Malignancies' interactive format will enable more collaborative discussion between faculty and conference participants.

"By receiving expert viewpoints and guidance on both sides of controversial issues that oncologists face in daily practice, they are able to make more well-informed decisions based on individual patient needs," said Chris Bolwell, COO of Imedex. "We are delighted to continue our partnership with the chairs and faculty to bring the gastrointestinal oncology community such an outstanding educational opportunity."

2017 marks the eighth annual conference, which will be chaired by Axel Grothey, MD (Mayo Clinic) and David H. Ilson, MD, PhD (Memorial Sloan-Kettering Cancer Center). As in past years, the meeting will be certified and organized by Imedex, an industry leader in providing CME programs in a live conference setting and online. Attendance is expected to be over 300 this year, and will likely be the largest annual gathering to date. Visit http://www.greatdebatesingimalignancies.com for additional information, including a full agenda listing with faculty presenters.

###
About Imedex® 
Imedex is the industry leader in developing and delivering independent, accredited healthcare education. The Company’s programs specializing in hematology, oncology, and gastroenterology are provided through live events around the world as well as through effective online educational opportunities for on-the-go healthcare providers.

Imedex’s high-quality scientific programming translates the latest research into clinically relevant information. Our activities facilitate the needs of time-constrained healthcare professionals who are inundated by information through exceptional organization and outstanding educational value — all with a proven and sustained impact on patient care.

Imedex provides over 50,000 E-learning experiences annually and its live conferences have welcomed more than 100,000 attendees since 2001. The Company has a global footprint and operates in the United States, Europe, and Asia.

At Imedex, we believe education is the best medicine®. For more information on Imedex and upcoming conferences, visit us online at http://www.imedex.com, on our E-learning Center at http://elc.imedex.com, or via email at registration@imedex.com.

Other upcoming Imedex events: 

ESMO 19th World Congress on Gastrointestinal Cancer 
28 June – 1 July 2017 | Barcelona, Spain 
http://www.worldgicancer.com

Imedex

Imedex®, LLC
11675 Rainwater Drive, Suite 600, Alpharetta, GA 30009, USA

Your privacy is important to us. Please review Imedex's Online Privacy Policy at http://www.imedex.com/appweb/about/terms.asp.